You have 9 free searches left this month | for more free features.

stage IA cervical cancer

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Melanoma Trial run by the National Cancer Institute (NCI) (Aldesleukin, Fludarabine, Cyclophosphamide)

Completed
  • Metastatic Melanoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 21, 2022

Breast Cancer Trial (Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F

Not yet recruiting
  • Breast Cancer
  • Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F Conjugates for Injection (FS-1502)
  • Control drug: Trastuzumab emtansine (Kadcyla, T-DM1)
  • (no location specified)
Feb 22, 2023

Gastric Cancer Trial in Japan, Korea, Republic of, Taiwan (ONO-4538, Ipilimumab, Oxaliplatin)

Recruiting
  • Gastric Cancer
  • Kashiwa-shi, Chiba, Japan
  • +56 more
Jun 1, 2022

PreDiabetes Trial (transtheoretical model)

Not yet recruiting
  • PreDiabetes
  • transtheoretical model
  • (no location specified)
Jan 19, 2022

Preconception Care Trial in Maseru (mHealth Application)

Active, not recruiting
  • Preconception Care
  • mHealth Application
  • Maseru, Lesotho
    Lesotho Boston Health Alliance
Aug 4, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Lobular Carcinoma, Metastatic Breast Lobular Carcinoma Trial in Atlanta

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Computed Tomography
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 9, 2022

Application of Antiosteoporosis Therapy in Osteolysis

Not yet recruiting
  • Limb; Fusion
  • Complication
  • Anti-osteoporosis therapy
  • Zhengzhou, Henan, China
    Department of Bone and Soft Tissue ,Henan Cancer Hospital
Jan 12, 2023

Pancreatic Cancer Trial in Omaha (Methylnaltrexone bromide, Placebo)

Withdrawn
  • Pancreatic Cancer
  • Methylnaltrexone bromide
  • Placebo
  • Omaha, Nebraska
    Bausch Site 001
May 5, 2021

Urinary Bladder Tumors Trial in Worldwide (drug, other, biological)

Active, not recruiting
  • Urinary Bladder Neoplasms
  • Aurora, Colorado
  • +102 more
Nov 16, 2022

Ovarian Cancer Trial in Zagazig (laparoscopy then primary cytoreductive surgery, laparoscopy then neoadjuvant chemo followed by

Completed
  • Ovarian Cancer
  • laparoscopy then primary cytoreductive surgery
  • laparoscopy then neoadjuvant chemotherapy followed by interval cytoreductive surgery
  • Zagazig, Sharkia, Egypt
    Faculty of Medicine, Zagazig Univeristy
Oct 1, 2022

Atherosclerotic Cardiovascular Disease Trial (Notification of CAC, Usual Care)

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • Notification of CAC
  • Usual Care
  • (no location specified)
Jul 28, 2023

Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Charlotte (Transarterial embolization, Microwave Ablation)

Terminated
  • Hepatocellular Carcinoma
  • +4 more
  • Transarterial embolization
  • Microwave Ablation
  • Charlotte, North Carolina
    Carolinas Medical Center
Apr 20, 2022

NSCLC Trial (DEB-BACE(Drug-eluting beads bronchial arterial chemoembolization))

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • DEB-BACE(Drug-eluting beads bronchial arterial chemoembolization)
  • (no location specified)
Apr 7, 2021

Prospective Androgen Receptor Signaling Inhibitors Resistance

Not yet recruiting
  • Prostate Cancer
  • +3 more
    • (no location specified)
    Nov 15, 2023

    Head and Neck Squamous Cell Carcinoma, Radiotherapy, Radiosensitizer Trial in China (Pirfenidone, Placebo)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +3 more
    • Guangzhou, Guangdong, China
    • +4 more
    Nov 16, 2023

    Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)

    Recruiting
    • Metastatic Breast Cancer
    • Trastuzumab deruxtecan
    • +6 more
    • Iowa City, Iowa
    • +60 more
    Jan 3, 2023

    Chronic Lymphocytic Leukemia (CLL) Trial in United States (Obinutuzumab, Venetoclax)

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Basking Ridge, New Jersey
    • +6 more
    Jan 3, 2023

    Liver Metastases, Breast Cancer Trial in Leuven, Amsterdam (Quiremspheres™)

    Recruiting
    • Liver Metastases
    • Breast Cancer
    • Quiremspheres™
    • Leuven, Vlaams-Brabant, Belgium
    • +1 more
    Nov 16, 2023

    End Stage Renal Disease Trial in Asunción (Implant of STARgraft-3 shunt in the upper arm and subsequent use for hemodialysis

    Recruiting
    • End Stage Renal Disease
    • Implant of STARgraft-3 shunt in the upper arm and subsequent use for hemodialysis access
    • Asunción, Paraguay
      Italian Hospital
    Feb 6, 2023

    Patient-Specific Instrumentation in Total Ankle Arthroplasty

    Not yet recruiting
    • Ankle Osteoarthritis
    • CT scan
    • (no location specified)
    Feb 14, 2023

    Metastatic Castration Resistant Prostate Cancer, Prostate Tumors Trial run by the NCI (enzalutamide, CRLX101)

    Terminated
    • Metastatic Castration Resistant Prostate Cancer
    • Prostate Neoplasms
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jun 16, 2022

    Prostatic Tumors Trial in Japan (Androgen-deprivation Therapy (ADT), Bicalutamide, Abiraterone)

    Active, not recruiting
    • Prostatic Neoplasms
    • Androgen-deprivation Therapy (ADT)
    • +6 more
    • Akita, Japan
    • +76 more
    Jan 19, 2023

    Hepatocellular Carcinoma Trial in Yerevan

    Recruiting
    • Hepatocellular Carcinoma
      • Yerevan, Armenia
        Nikomed Medical Center
      Jun 28, 2023

      Advanced Cancer Trial in Beijing, Shanghai, Hangzhou (TST001 injection)

      Recruiting
      • Advanced Cancer
      • TST001 injection
      • Beijing, Beijing, China
      • +2 more
      Apr 13, 2022

      Acute Kidney Injury, Peritonitis, Necrotizing Soft Tissue Infection Trial in France, United States (Reltecimod 0.5 mg/kg,

      Terminated
      • Acute Kidney Injury
      • +2 more
      • Reltecimod 0.5 mg/kg
      • Placebo
      • Phoenix, Arizona
      • +55 more
      Sep 17, 2021